"Not sticking up for LC or any other BOD member here - just saying that data and a results will determine success or failure. Not who is running or managing the company."
Financial management, ie how far the funds stretch and keeping to budget is governed by management. Hundreds of millions raised and the result is our only phase 2 completed drug shelved and unsellable and we're scraping the barrel to fund phase 1 trials of new drugs. The buck stops at the CEO.
Delivering data on time is governed by management, see end 2024 self-set data release deadline missed by LC. The buck stops at the CEO.
The data will inform the end result here but the process in between is vast and is controlled by management, with the buck stopping at the CEO.
Better the devil you know, or better odds of timely success with much less pain and dilution with new management? My opinion is that it is time for fresh blood. LC is a CMO at best and has had many many years to prove otherwise.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)